Hosszúfalusi Nóra, Vatay Agnes, Rajczy Katalin, Prohászka Zoltán, Pozsonyi Eva, Horváth Laura, Grosz Andrea, Gerõ László, Madácsy László, Romics László, Karádi István, Füst George, Pánczél Pál
Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
Diabetes Care. 2003 Feb;26(2):452-7. doi: 10.2337/diacare.26.2.452.
To compare the clinical parameters, C-peptide levels, pattern of islet cell-specific autoantibodies, and prevalence of predisposing genotypes in subjects with latent autoimmune diabetes in adults (LADA) and those with adult-onset type 1 diabetes with rapid progression.
We evaluated the clinical parameters, C-peptide levels, and islet cell-specific autoantibodies in 54 LADA, 57 adult-onset type 1 diabetic, and 190 type 2 diabetic patients. Islet cell autoantibodies were also compared between subgroups of newly diagnosed patients with LADA and those with newly diagnosed adult-onset and childhood-onset type 1 diabetes. The genetic study was performed in subjects with LADA and those with adult-onset type 1 diabetes in comparison with a control population.
There were no differences in the clinical parameters between LADA and adult-onset type 1 diabetes. Patients with LADA had lower BMI (P < 0.0001), waist-to-hip ratio (0.0029), total cholesterol (P = 0.001), and triglycerides (P = 0.001); higher HDL cholesterol levels (P < 0.0001); and lower prevalence of hypertension (P = 0.0028) compared with patients with type 2 diabetes. C-peptide levels were similar at onset (P = 0.403) but decreased less rapidly in LADA than in adult-onset type 1 diabetes (P = 0.0253). Single-autoantibody positivity was more often seen in LADA than in type 1 diabetes (P = 0.0001). The prevalence of predisposing HLA-DQB10302, -DR4, -DR3, and -DR3/DR4 genotypes and the DR4-DQB10302 haplotype were increased in both LADA and adult-onset type 1 diabetic subjects compared with the control population. There were no differences in the frequencies of these risk alleles and haplotypes between the two patient groups.
Subjects with LADA had clinical characteristics similar to those with adult-onset type 1 diabetes with rapid progression. C-peptide levels did not differ at onset but decreased less rapidly in LADA. Patients with LADA rather had single islet cell-specific autoantibody positivity. The prevalence of HLA-DQB10302, -DR4, -DR3, and -DR3/DR4 risk alleles and the DR4-DQB10302 high-risk haplotype did not differ in the two forms of autoimmune diabetes.
比较成人隐匿性自身免疫性糖尿病(LADA)患者与成人起病的快速进展型1型糖尿病患者的临床参数、C肽水平、胰岛细胞特异性自身抗体模式以及易感基因型的患病率。
我们评估了54例LADA患者、57例成人起病的1型糖尿病患者和190例2型糖尿病患者的临床参数、C肽水平及胰岛细胞特异性自身抗体。还比较了新诊断的LADA患者亚组与新诊断的成人起病和儿童起病的1型糖尿病患者亚组之间的胰岛细胞自身抗体。对LADA患者和成人起病的1型糖尿病患者与对照人群进行了基因研究。
LADA患者与成人起病的1型糖尿病患者在临床参数上无差异。与2型糖尿病患者相比,LADA患者的体重指数(P<0.0001)、腰臀比(0.0029)、总胆固醇(P=0.001)和甘油三酯(P=0.001)较低;高密度脂蛋白胆固醇水平较高(P<0.0001);高血压患病率较低(P=0.0028)。起病时C肽水平相似(P=0.403),但LADA患者C肽水平下降速度比成人起病的1型糖尿病患者慢(P=0.0253)。LADA患者比1型糖尿病患者更常出现单一自身抗体阳性(P=0.0001)。与对照人群相比,LADA患者和成人起病的1型糖尿病患者中易感的HLA-DQB10302、-DR4、-DR3和-DR3/DR4基因型以及DR4-DQB10302单倍型的患病率均升高。两组患者这些风险等位基因和单倍型的频率无差异。
LADA患者的临床特征与成人起病的快速进展型1型糖尿病患者相似。起病时C肽水平无差异,但LADA患者C肽水平下降速度较慢。LADA患者更常出现单一胰岛细胞特异性自身抗体阳性。两种自身免疫性糖尿病形式中,HLA-DQB10302、-DR4、-DR3和-DR3/DR4风险等位基因以及DR4-DQB10302高风险单倍型的患病率无差异。